期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

重组人促卵泡激素质量控制中理化测定代替生物测定简介 被引量：2

Physicochemical methods alternative for bioassays for recombinant human follicle-stimulating hormone in quality control
原文传递
导出
摘要 本文综述重组人促卵泡激素(rhFSH)质量控制中的生物测定的作用与局限性。对长期批次间一致的rhFSH产品,理化测定将代替生物效价的测定,但在研发阶段仍需选择生物测定。 Limitations and role of the bioassay for recombinant human folliclestimulating hormone（ rhFSH） were reviewed. It is clarified that the physicochemical determination will substitute the potency determination for rhFSH preparations which have long term batchtobatch consistency while bioassay would still be chosen in the research and development stage.
作者 李湛军 梁成罡 杨化新
机构地区 中国食品药品检定研究院
出处 《药物分析杂志》 CAS CSCD 北大核心 2014年第9期1524-1529,共6页 Chinese Journal of Pharmaceutical Analysis
基金 十二五重大新药创制-创新药物研究开发技术平台建设(No.2012ZX09304010)
关键词 重组人促卵泡激素 体内生物测定 理化方法 替代 比活性 批次间一致性 rhFSH in vivo bioassay physicochemical methods substitution specific activity batch-to-batch consistency
分类号 R917 [医药卫生—药物分析学]
  • 相关文献

参考文献55

  • 1Stanton PG,Burgon PG,Hearn MT,et al.Structural and functional characterisation of hFSH and hLH isoforms[J].Mol Cell Endocrinol,1996,125(1-2):133.
  • 2Lombardi A,Andreozzi C,Pavone V,et al.Evaluation of the oligosaccharide composition of commercial follicle stimulating hormone preparations[J].Electrophoresis,2013,34(16):2394.
  • 3Chappel SC.Heterogeneity of follicle stimulating hormone:control and physiological function[J].Hum Reprod Update,1995,1(5):479.
  • 4Laan M,Grigorova M,Huhtaniemi IT.Pharmacogenetics of follicle-stimulating hormone action[J].Curr Opin Endocrinol Diabetes Obes,2012,19(3):220.
  • 5Siebold B.Physicochemical characterization of recombinant human follicle-stimulating hormone[J].Hum Reprod Update,1996,11(1):109.
  • 6Ben-Rafael Z,Levy T,Schoemaker J.Pharmacokinetics of follicle-stimulating hormone:clinical significance[J].Fertil Steril,1995,63(4):689.
  • 7Daya S.Follicle-stimulating hormone in clinical practice:an update[J].Treat Endocrinol,2004,3(3):161.
  • 8Fatemi HM,Blockeel C,Devroey PO.Ovarian stimulation:today and tomorrow[J].Curr Pharm Biotechnol,2012,13(3):392.
  • 9Howles CM.Recombinant gonadotrophins in reproductive medicine:the gold standard of today[J].Reprod Biomed Online,2006,12(1):11.
  • 10Efesoy O,Cayan S,Ahkbay E,et al.The efficacy of recombinant human follicle-stimulating hormone in the treatment of various types of male-factor infertility at a single university hospital[J].J Androl,2009,30(6):679.

二级参考文献49

  • 1李湛军,徐康森.浅淡生化药质量标准中的异常毒性等安全性检查[J].中国药品标准,2006,7(5):17-18. 被引量：9
  • 2李湛军,徐康森.生化药物质量控制中生物测定的作用与局限[J].药物分析杂志,2007,27(2):297-301. 被引量：9
  • 3ZHOU Hai-jun(周海钧).Technical Requirements for Registration of Pharmaceuticals for Human Use(药品注册的国际技术要求).Bering(北京):People’s Medical Publishing House(人民卫生出版社),2007.289.
  • 4WANG Jun-zhi(乇军志).Research, Development and Quality Control for Biopharmaceuticals(生物技术药物研究开发和质量控制).2nd Ed(第二版).Beijing(北京):Science Press(科学出版社),2007.
  • 5FA Fares,Nachman G, Kraiem Z, et al. The role of the asparaginelinked oligosaccharides of the α - subunit in human thyrotropin bioactivity. Endocrinology, 1996,137 (2) : 555.
  • 6Wiebe O, Willem de B, John WM, et al. Molecular biology and biochemistry of human recombinant follicle stimulating hormone ( Puregon ). Mol Hum Reprod ,1996 ,2 ( 5 ) :371.
  • 7Recombinant Human FSH Product Development.Group Recombinant follicle stimulating hormone:development of the first biotechnology product for the treatment of infertility[J].Hum Reprod Update,1998,4(6):862-881.
  • 8Jeffery L K,Martin M M,Tetsuo O,et al.Expression of biologically active human follitropin in Chinese hamster ovary cell[J].J Biol Chemvol,264(8):4769-4775.
  • 9周海钧.ICH(药品注册的国际技术要求)[M].北京:人民卫生出版社,2007:289-291.
  • 10Wiebe O,Willem de B,John W M,et al.Molecular biology and biochemistry of human recombinant follicle stimulating hormone(Puregon(R))[J].Mol Hum Reprod,1996,2(5):371.

共引文献34

同被引文献22

  • 1ChP 2010.Vol Ⅱ(中国药典2010年版.二部)[S].2010:976.
  • 2PAULINE C, ALLAN EH. Optogenetic activation of GnRH neurons reveals minimal requirements for pulsatile luteinizing hormone secretion[J]. Proc Natl Acad Sci USA, 2014, 111(51):18387.
  • 3ZHOU HJ(周海钧). The Drug Bioassay(药品生物检定)[M]. Beijing(北京):People's Medical Publishing House(人民卫生出版社), 2005:223.
  • 4LENG W(冷炜). Bioassay of the Drug(药品的生物检定)[M]. Beijing(北京):Meteorological Press(气象出版社), 1995:114.
  • 5QIAN DM(钱德明), LIU QL(刘群丽), ZHANG Y(张媛). Collaboration of the third national standard reference potency for human menopausal gonadotropin(尿促性素第三批国家标准品的标定)[J]. Drug Stand China(中国药品标准), 2007, 8(5):49.
  • 6National Institute for the Control of Pharmaceutical and Biological Products(中国药品生物制品检定所). Standard Operating Procedure for Chinese Drug Test(中国药品检验标准操作规范)[M]. Beijing(北京):China Medical Science Press (中国医药科技出版社), 2010:489.
  • 7ROSE MP, GAINES DAS RE, BALEN AH. Definition and measurement of follicle stimulating hormone[J]. Endocr Rev, 2000, 21(1): 5.
  • 8钱德明,刘群丽,李波.重组人促黄体生成素国际标准品的协作标定[J].中国药品标准,2007,8(5):49-50. 被引量：5
  • 9贺庆,刘群丽,张媛,高华,谭德讲,钱德明.第5批绒促性素国际标准品协作标定[J].中国药事,2013,27(4):405-410. 被引量：6
  • 10贺庆,曹秀堂,谭德讲,高华,李冠民.生物测定法替代研究中统计学的应用[J].药物分析杂志,2013,33(11):1852-1857. 被引量：1

引证文献2

二级引证文献3

药物分析杂志
2014年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部